Evidence map›Paper›PMID 29261847›Full record

ArticleInvestigative ophthalmology & visual science2017

TSC1 Mutations in Keratoconus Patients With or Without Tuberous Sclerosis.

Yelena Bykhovskaya, Majid Fardaei, Mariam Lotfy Khaled, Mahmood Nejabat, Ramin Salouti, Hassan Dastsooz, Yutao Liu, Soroor Inaloo, Yaron S Rabinowitz

Open access · goldAbstract read
In one paragraph

Article in Investigative ophthalmology & visual science, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed, 1 pooled it
0.6field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 1 synthesis or guideline pooled it, 13 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 2 countries.

Yelena BykhovskayaDepartment of Surgery and Board of the Governors Regenerative Medicine Institute, Cedars-Sinai Medical Center, Los Angeles, California, United States.
Majid FardaeiDepartment of Medical Genetics, Shiraz University of Medical Sciences, Shiraz, Iran.
Mariam Lotfy KhaledDepartment of Cellular Biology and Anatomy, Augusta University, Augusta, Georgia, United States.
Mahmood NejabatPoostchi Ophthalmology Research Center, Department of Ophthalmology, Shiraz University of Medical Sciences, Shiraz, Iran.
Ramin SaloutiPoostchi Ophthalmology Research Center, Department of Ophthalmology, Shiraz University of Medical Sciences, Shiraz, Iran.
Hassan DastsoozComprehensive Medical Genetics Center, Shiraz University of Medical Sciences, Shiraz, Iran.
Yutao LiuDepartment of Cellular Biology and Anatomy, Augusta University, Augusta, Georgia, United States.
Soroor InalooDepartment of Pediatrics, Shiraz University of Medical Sciences, Shiraz, Iran.
Yaron S RabinowitzDepartment of Surgery and Board of the Governors Regenerative Medicine Institute, Cedars-Sinai Medical Center, Los Angeles, California, United States.
Shiraz University of Medical Sciences · IRAugusta University · USCedars-Sinai Medical Center · US

Funding

GENETIC FACTORS IN KERATOCONUSR01EY009052 · NEI · CEDARS-SINAI MEDICAL CENTER · PI RABINOWITZ, YARON SOLOMON, ROTTER, JEROME I · 1993 to 2019
$10.9M
Gene Discovery in Familial KeratoconusR01EY023242 · NEI · DUKE UNIVERSITY · PI LIU, YUTAO · 2013 to 2023
$3.4M
NEI NIH HHS R01 EY009052NEI NIH HHS R01 EY023242
6 · The paper itself

Abstract

Purpose: To test candidate genes TSC1 and TSC2 in a family affected by tuberous sclerosis complex (TSC) where proband was also diagnosed with bilateral keratoconus (KC) and to test the hypothesis that defects in the same gene may lead to a nonsyndromic KC. Methods: Next-generation sequencing of TSC1 and TSC2 genes was performed in a proband affected by TSC and KC. Identified mutation was confirmed by Sanger DNA sequencing. Whole exome sequencing (WES) was performed in patients with nonsyndromic KC. Sanger DNA sequencing was used to confirm WES results and to screen additional patients. RT-PCR was used to investigate TSC1 expression in seven normal human corneas and eight corneas from patients with KC. Various in silico tools were employed to model functional consequences of identified mutations. Results: A heterozygous nonsense TSC1 mutation g.132902703C>T (c.2293C>T, p.Gln765Ter) was identified in a patient with TSC and KC. Two heterozygous missense TSC1 variants g.132896322A>T (c.3408A>T, p.Asp1136Glu) and g.132896452G>A (c.3278G>A, p.Arg1093Gln) were identified in three patients with nonsyndromic KC. Two mutations were not present in The Genome Aggregation (GnomAD), The Exome Aggregation (ExAC), and 1000 Genomes (1000G) databases, while the third one was present in GnomAD and 1000G with minor allele frequencies (MAF) of 0.00001 and 0.0002, respectively. We found TSC1 expressed in normal corneas and KC corneas, albeit with various levels. Conclusions: Here for the first time we found TSC1 gene to be involved in bilateral KC and TSC as well as with nonsyndromic KC, supporting the hypothesis that diverse germline mutations of the same gene can cause genetic disorders with overlapping clinical features.

Indexed as

MutationAdultChild, PreschoolDNADNA Mutational AnalysisFemaleHumansKeratoconusMaleMicroscopy, AcousticPedigreeReverse Transcriptase Polymerase Chain ReactionTomography, X-Ray ComputedTuberous SclerosisTuberous Sclerosis Complex 1 ProteinTumor Suppressor ProteinsDNATSC1 protein, humanTuberous Sclerosis Complex 1 ProteinTumor Suppressor Proteins

Identifiers

PMID29261847
PMCPMC5760196
OpenAlexW2780309358

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.